Research News
View articles by month and year
-
Ixempra Approved to Treat Advanced-Stage Breast Cancer
Ixempra (chemical name: ixabepilone) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancers after other chemotherapy medicines have stopped working.
-
Exercise Boosts Self-Esteem During Chemo
Exercise can boost self-esteem, fitness, and treatment completion rates for women getting chemotherapy.
-
Some Women Don’t Benefit from Adding Taxol to Chemo Regimen
An early breast cancer's HER2 status affects the benefits offered by Taxol.
-
Chemo Raises Leukemia Risk Slightly in Older Women
Women who receive chemotherapy have a small increase in risk for a type of leukemia later in life.
-
Ixabepilone Gets Faster Review
Ixabepilone, a new chemotherapy medication for advanced breast cancer, has been given priority review by the U.S. Food and Drug Administration.
-
Chemo and Radiation at the Same Time Improve Prognosis for Early-Stage Disease
Research suggests that treatment with chemotherapy and radiation at the same time can help keep breast cancer from coming back.
-
Certain High-dose Regimen Linked to Chemobrain
Research shows that thinking and memory problems are linked to a chemotherapy regimen.
